ArticleCell communication and signaling : CCS2025

Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma.

Su In Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.